Primary Country (Mandatory)

Other Country (Optional)

Set News Language for United States

Primary Language (Mandatory)
Other Language[s] (Optional)
No other language available

Set News Language for World

Primary Language (Mandatory)
Other Language(s) (Optional)

Set News Source for United States

Primary Source (Mandatory)
Other Source[s] (Optional)

Set News Source for World

Primary Source (Mandatory)
Other Source(s) (Optional)
  • Countries
    • India
    • United States
    • Qatar
    • Germany
    • China
    • Canada
    • World
  • Categories
    • National
    • International
    • Business
    • Entertainment
    • Sports
    • Special
    • All Categories
  • Available Languages for United States
    • English
  • All Languages
    • English
    • Hindi
    • Arabic
    • German
    • Chinese
    • French
  • Sources
    • India
      • AajTak
      • NDTV India
      • The Hindu
      • India Today
      • Zee News
      • NDTV
      • BBC
      • The Wire
      • News18
      • News 24
      • The Quint
      • ABP News
      • Zee News
      • News 24
    • United States
      • CNN
      • Fox News
      • Al Jazeera
      • CBSN
      • NY Post
      • Voice of America
      • The New York Times
      • HuffPost
      • ABC News
      • Newsy
    • Qatar
      • Al Jazeera
      • Al Arab
      • The Peninsula
      • Gulf Times
      • Al Sharq
      • Qatar Tribune
      • Al Raya
      • Lusail
    • Germany
      • DW
      • ZDF
      • ProSieben
      • RTL
      • n-tv
      • Die Welt
      • Süddeutsche Zeitung
      • Frankfurter Rundschau
    • China
      • China Daily
      • BBC
      • The New York Times
      • Voice of America
      • Beijing Daily
      • The Epoch Times
      • Ta Kung Pao
      • Xinmin Evening News
    • Canada
      • CBC
      • Radio-Canada
      • CTV
      • TVA Nouvelles
      • Le Journal de Montréal
      • Global News
      • BNN Bloomberg
      • Métro
Pfizer, Others To Get Indemnity? "No Problem," Say Government Sources

Pfizer, Others To Get Indemnity? "No Problem," Say Government Sources

NDTV
Wednesday, June 02, 2021 05:21:47 AM UTC

Health Ministry sources have said other countries have done it and "there is no problem" in granting indemnity or legal protection from any claims linked to the use of a company's COVID-19 vaccine.

To speed up approvals for Pfizer and Moderna in India, the government may grant a major concession requested by them - indemnity from liability. Health Ministry sources have said other countries have done it and "there is no problem" in granting indemnity or legal protection from any claims linked to the use of a company's COVID-19 vaccine. "If these companies have applied for Emergency Use Authorisation in India, then we are ready to give them indemnity," the sources said. In another key waiver, the drug regulator has done away with the requirement of India-specific trials for foreign vaccines approved by specific countries and WHO for emergency use.
Read full story on NDTV
Share this story on:-
More Related News
© 2008 - 2025 Webjosh  |  News Archive  |  Privacy Policy  |  Contact Us